By continuing to use our site, you agree to our Terms of Use and Privacy Policy. You can learn more about how we use cookies by reviewing our Privacy Policy.

I Agree

About Pisit “Duke” Pitukcheewanont, MD, FAAP:

Dr Pisit “Duke” Pitukcheewanont is Senior Vice President of Global Clinical Development and Medical Affairs. Dr Pitukcheewanont is a pediatric endocrinologist and is also a Professor of Clinical Pediatrics at the Children’s Hospital of Los Angeles, Keck School of Medicine of the University of Southern California, where he has worked as a faculty physician since 1998. Most recently, Dr. Duke served as Vice President of Medical Affairs and Vice President, Global Medical Ambassador and Medical Education at Ascendis Pharma where he was involved in the development and pre-launch medical affair efforts of Skytrofa ©, the once-weekly injectable for pediatric growth hormone deficiency. Dr. Duke has served on multiple advisory and executive boards for noted pharmaceutical and rare disease companies. He has presented numerous times at national and international medical conferences and has appeared on local and national news platforms giving his expertise on pediatric endocrine disorders. During his career, he has received numerous research grants and has authored over 70 publications.  


Since 2007, Dr. Duke has also served in many leaderships roles for the Human Growth Foundation (HGF), where he has been instrumental in raising the organization’s profile and involvement in the endocrine community and spearheading its support of research, education, and patient advocacy related to growth disorders. In 2011, he was elected President of the HGF where he served until the end of 2021. He has been elected in October 2022 to serve as the HGF President until present. 


Dr Pitukcheewanont received his MD from Chiang Mai University in Thailand as well as completing his pediatric residency. He also completed an internship, residency and fellowship in diabetes, endocrinology & metabolism at University of Tennessee, at both their Memphis and Knoxville campuses.